Skip to main content
. 2003 Feb;55(2):126–133. doi: 10.1046/j.1365-2125.2003.01727.x

Table 1.

Inclusion/exclusion criteria.

Inclusion criteria
 Male or female patients over 18 years & up to 75 years of age Inability to remain at the hospital for the duration of the study Hip or knee
 Grade I-II physical status as defined by the American Society of replacement surgery under general anaesthesia (24 h)
 Anaesthesiologists [24]Grade I-II physical status as defined by the American Society of Morphine not the drug of choice for patient-controlled analgesia
 Written informed consentAnaesthesiologists [24]
Exclusion criteria
 Inability to remain at the hospital for the duration of the study
 Hip or knee replacement surgery under general anaesthesia (24 h)
 Morphine not the drug of choice for patient-controlled analgesia
 Contraindication for treatment with ketoprofen or other nonsteroidal
 Written informed consentsteroidal anti-inflammatory drugs
 Systemic infection or infection at the site of operation before surgery is is performed
 Complication during or after surgical procedure
 Patients with planned concomitant medication during the study with any of of the following: lithium, more than 300 mg acetyl salicylic acid per day, other nonsteroidal anti-inflammatory drugs, systemic glucocorticoids, methotrexate, cyclosporin, sedatives (other than short acting premedications), MAO inhibitors, inhibitors, antiepileptics
 Allergy to ketoprofen or other nonsteroidal anti-inflammatory drugs
 History of peptic ulcer, gastrointestinal bleeding or severe gastropathy gastropathy
 Moderate or severe renal, hepatic or respiratory impairment in the opinion opinion of the investigator
 Recent history of asthma, bronchospasm, angioedema or coagulation disorder
 Diabetes mellitus, heart failure or hypertension not well controlled
 Drug addiction or alcoholism
 Epilepsy, psychosis or other psychiatric disorders
 Current participation or participation within the previous 3 months in other clinical trials with unlicensed medicines or in other clinical trial with unlicensed medicines in the previous 3 months.
 Pregnancy or lactation, including ectopic pregnancy
 Inadequate contraception (females)